持有 金域医学(603882)的基金 |
报告期:2021-12-31 |
序号 |
基金代码 |
基金简称 |
持仓市值(元) |
持仓数量(股) |
占基金净值比例(%) |
1 | 001217 | 易方达新收益混合C | 576,770,863.27 | 5,178,871.00 | 6.04 |
2 | 001216 | 易方达新收益混合A | 576,770,863.27 | 5,178,871.00 | 6.04 |
3 | 000171 | 易方达裕丰回报债券 | 425,288,619.00 | 3,818,700.00 | 1.04 |
4 | 512170 | 华宝中证医疗ETF | 329,172,967.90 | 2,955,670.00 | 2.34 |
5 | 010454 | 交银内需增长一年混合 | 309,478,185.73 | 2,778,829.00 | 6.57 |
6 | 050026 | 博时医疗保健行业混合A | 242,703,629.35 | 2,179,255.00 | 4.70 |
7 | 002969 | 易方达丰和债券 | 229,744,282.04 | 2,062,892.00 | 0.82 |
8 | 006113 | 添富创新医药混合 | 202,598,958.24 | 1,819,152.00 | 1.93 |
9 | 110027 | 易方达安心回报债券A | 197,191,833.37 | 1,770,601.00 | 0.71 |
10 | 110028 | 易方达安心回报债券B | 197,191,833.37 | 1,770,601.00 | 0.71 |
11 | 004075 | 交银医药创新股票 | 160,703,457.53 | 1,442,969.00 | 4.10 |
12 | 004868 | 交银股息优化混合 | 156,269,038.24 | 1,403,152.00 | 6.55 |
13 | 519714 | 交银消费新驱动股票 | 148,592,526.88 | 1,334,224.00 | 6.58 |
14 | 005004 | 交银品质升级混合 | 132,835,008.32 | 1,192,736.00 | 6.56 |
15 | 010187 | 嘉实核心成长混合C | 132,426,391.79 | 1,189,067.00 | 1.45 |
16 | 010186 | 嘉实核心成长混合A | 132,426,391.79 | 1,189,067.00 | 1.45 |
17 | 000751 | 嘉实新兴产业股票 | 130,249,331.03 | 1,169,519.00 | 1.22 |
18 | 010387 | 易方达医药生物股票A | 122,967,849.06 | 1,104,138.00 | 4.70 |
19 | 010388 | 易方达医药生物股票C | 122,967,849.06 | 1,104,138.00 | 4.70 |
20 | 260110 | 景顺长城精选蓝筹混合 | 121,832,543.28 | 1,093,944.00 | 5.01 |
21 | 001603 | 易方达安盈回报混合 | 121,136,146.67 | 1,087,691.00 | 3.29 |
22 | 008063 | 汇添富大盘核心资产混合 | 116,938,500.00 | 1,050,000.00 | 2.88 |
23 | 110023 | 易方达医疗保健行业混合 | 115,386,336.31 | 1,036,063.00 | 2.67 |
24 | 009813 | 易方达悦兴一年持有期混合C | 113,730,598.52 | 1,021,196.00 | 1.14 |
25 | 009812 | 易方达悦兴一年持有期混合A | 113,730,598.52 | 1,021,196.00 | 1.14 |
26 | 010025 | 广发聚丰混合C | 111,370,000.00 | 1,000,000.00 | 2.04 |
27 | 270005 | 广发聚丰混合A | 111,370,000.00 | 1,000,000.00 | 2.04 |
28 | 512010 | 易方达沪深300医药ETF | 108,153,968.51 | 971,123.00 | 1.44 |
29 | 010276 | 嘉实优质精选混合C | 107,376,049.06 | 964,138.00 | 5.62 |
30 | 010275 | 嘉实优质精选混合A | 107,376,049.06 | 964,138.00 | 5.62 |
31 | 512290 | 国泰中证生物医药ETF | 107,240,845.88 | 962,924.00 | 2.73 |
32 | 009264 | 泓德瑞兴三年持有期混合 | 107,183,156.22 | 962,406.00 | 1.17 |
33 | 519008 | 汇添富优势精选混合 | 105,801,500.00 | 950,000.00 | 3.12 |
34 | 009795 | 嘉实远见精选两年持有期混合 | 102,335,776.97 | 918,881.00 | 1.26 |
35 | 009618 | 交银启汇混合 | 102,290,449.38 | 918,474.00 | 3.88 |
36 | 008131 | 景顺长城竞争优势混合 | 99,987,986.00 | 897,800.00 | 2.76 |
37 | 510300 | 华泰柏瑞沪深300ETF | 92,434,761.23 | 829,979.00 | 0.16 |
38 | 090001 | 大成价值增长混合 | 91,925,688.96 | 825,408.00 | 4.93 |
39 | 501006 | 汇添富中证精准医指数(LOF)C | 89,778,141.25 | 806,125.00 | 5.18 |
40 | 501005 | 汇添富中证精准医指数(LOF)A | 89,778,141.25 | 806,125.00 | 5.18 |
41 | 001766 | 上投摩根医疗健康股票 | 66,532,549.37 | 597,401.00 | 4.83 |
42 | 000595 | 嘉实泰和混合 | 65,868,561.43 | 591,439.00 | 1.19 |
43 | 010348 | 景顺长城泰保三个月定开混合 | 65,271,729.60 | 586,080.00 | 2.55 |
44 | 010104 | 景顺长城消费精选混合A | 62,990,872.00 | 565,600.00 | 2.69 |
45 | 010105 | 景顺长城消费精选混合C | 62,990,872.00 | 565,600.00 | 2.69 |
46 | 470006 | 汇添富医药保健混合A | 62,076,969.78 | 557,394.00 | 1.05 |
47 | 010134 | 广发新经济混合C | 61,262,632.34 | 550,082.00 | 3.20 |
48 | 270050 | 广发新经济混合A | 61,262,632.34 | 550,082.00 | 3.20 |
49 | 519670 | 银河行业混合 | 55,897,939.44 | 501,912.00 | 4.00 |
50 | 003494 | 富国天惠成长混合(LOF)C | 55,740,685.00 | 500,500.00 | 0.14 |
51 | 161005 | 富国天惠成长混合(LOF)A | 55,740,685.00 | 500,500.00 | 0.14 |
52 | 519017 | 大成积极成长混合 | 54,838,588.00 | 492,400.00 | 3.17 |
53 | 510180 | 华安上证180ETF | 54,791,144.38 | 491,974.00 | 0.24 |
54 | 008712 | 景顺长城品质成长混合 | 53,190,312.00 | 477,600.00 | 2.70 |
55 | 008140 | 汇添富绝对收益定开混合C | 49,292,362.00 | 442,600.00 | 0.19 |
56 | 000762 | 汇添富绝对收益定开混合A | 49,292,362.00 | 442,600.00 | 0.19 |
57 | 519710 | 交银策略回报混合 | 49,171,080.07 | 441,511.00 | 6.40 |
58 | 000311 | 景顺长城沪深300指数增强 | 47,199,496.96 | 423,808.00 | 0.90 |
59 | 070099 | 嘉实优质企业混合 | 46,524,149.28 | 417,744.00 | 2.11 |
60 | 009137 | 嘉实瑞和两年持有期混合 | 45,537,076.97 | 408,881.00 | 1.35 |
61 | 502056 | 广发中证医疗指数(LOF)A | 44,180,479.00 | 396,700.00 | 2.29 |
62 | 009881 | 广发中证医疗指数(LOF)C | 44,180,479.00 | 396,700.00 | 2.29 |
63 | 002808 | 泓德优势领航混合 | 43,512,259.00 | 390,700.00 | 2.11 |
64 | 008150 | 嘉实远见企业精选两年持有期混合 | 41,500,582.69 | 372,637.00 | 2.28 |
|